Stella Papa MD
Education
Degrees
- Certified Neurologist from Argentine Public Health Ministry,
- No Degree from National University of Buenos Aires. School of Philosophy
- MD from National University of Buenos Aires
Research
Focus
- My research is focused on Experimental Therapeutics for Parkinsons disease and other Movement Disorders. I am interested in understanding the pathophysiologic basis of these disorders to develop new and improved therapies. My studies of functional and structural alterations in basal ganglia networks use electrophysiological and pharmacological approaches.
Publications
-
Research Priorities on the Role of -Synuclein in Parkinson's Disease Pathogenesis.
Mov Disord Volume: 39 Page(s): 1663 - 1678
10/01/2024 Authors: Burr J; Edwards RH; Halliday G; Lang AE; Lashuel HA; Melki R; Murayama S; Outeiro TF; Papa SM; Stefanis L -
Targeting Striatal Glutamate and Phosphodiesterases to Control L-DOPA-Induced Dyskinesia.
Cells Volume: 12
11/30/2023 Authors: Kochoian BA; Bure C; Papa SM -
Phosphodiesterase 9 inhibition prolongs the antiparkinsonian action of l-DOPA in parkinsonian non-human primates.
Neuropharmacology Volume: 212 Page(s): 109060
07/01/2022 Authors: Masilamoni GJ; Sinon CG; Kochoian BA; Singh A; McRiner AJ; Leventhal L; Papa SM -
Reply to: "Letter on Discussionof Gait Research".
Mov Disord Volume: 37 Page(s): 1328
06/01/2022 Authors: Bohnen NI; Costa RM; Dauer WT; Factor SA; Giladi N; Hallett M; Lewis SJG; Nieuwboer A; Nutt JG; Takakusaki K -
Cortical Serotonergic and Catecholaminergic Denervation in MPTP-Treated Parkinsonian Monkeys.
Cereb Cortex Volume: 32 Page(s): 1804 - 1822
04/20/2022 Authors: Masilamoni GJ; Weinkle A; Papa SM; Smith Y -
Addressing the Challenges of Clinical Research for Freezing of Gait in Parkinson's Disease.
Mov Disord Volume: 37 Page(s): 264 - 267
02/01/2022 Authors: Lewis SJG; Factor SA; Giladi N; Hallett M; Nieuwboer A; Nutt JG; Przedborski S; Papa SM; MDS Scientific Issues Committee -
Discussion of Research Priorities for Gait Disorders in Parkinson's Disease.
Mov Disord Volume: 37 Page(s): 253 - 263
02/01/2022 Authors: Bohnen NI; Costa RM; Dauer WT; Factor SA; Giladi N; Hallett M; Lewis SJG; Nieuwboer A; Nutt JG; Takakusaki K -
Striatal FosB gene suppression inhibits the development of abnormal involuntary movements induced by L-Dopa in rats.
Gene Ther Volume: 28 Page(s): 760 - 770
12/01/2021 Authors: Beck G; Zhang J; Fong K; Mochizuki H; Mouradian MM; Papa SM -
Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease.
Mov Disord Volume: 36 Page(s): 1772 - 1780
08/01/2021 Authors: Barbuti PA; Barker RA; Brundin P; Przedborski S; Papa SM; Kalia LV; Mochizuki H; MDS Scientific Issues Committee -
COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel?
J Parkinsons Dis Volume: 11 Page(s): 3 - 8
01/01/2021 Authors: Bloem BR; Trenkwalder C; Sanchez-Ferro A; Kalia LV; Alcalay R; Chiang H-L; Kang UJ; Goetz C; Brundin P; Papa SM